Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· The Fertility Gynecologist Audio: English

Caloric restriction mimetics and ovarian aging: a video description overview

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

At a glance

Automatic summary · not editorially reviewed

The description says caloric restriction mimetics such as metformin, rapamycin, resveratrol and spermidine are being studied for ovarian aging and fertility, mainly in experimental and animal work; human evidence is limited and these are not proven fertility treatments. [1]

  1. The description says caloric restriction mimetics try to reproduce some cellular effects of caloric restriction without simply reducing food intake, and links them to nutrient sensing, autophagy, mitochondria, oxidative stress, AMPK, mTOR and sirtuins. [1]

  2. The description names metformin, rapamycin, resveratrol and spermidine as investigated compounds and says metformin should not be used solely for fertility or ovarian aging and rapamycin should not be self-administered for fertility. [1]

  3. The description says experimental work, particularly in animal models, has examined follicle preservation, oocyte quality and ovarian aging, but human evidence is limited and these findings are not proof of reversing ovarian aging or improving pregnancy rates in women. [1]

Pathways linked to caloric restriction mimetics

The description says caloric restriction mimetics are compounds or interventions that try to reproduce some cellular effects of caloric restriction without simply reducing food intake. It links these pathways to nutrient sensing, cellular metabolism, autophagy, mitochondrial function, oxidative stress, AMPK, mTOR and sirtuin signaling. AMPK is described as a cellular energy sensor, mTOR as involved in nutrient sensing, growth and metabolism, and sirtuins including SIRT1 as associated with cellular aging and metabolic regulation. The creator frames these mechanisms as interesting for ovarian aging, reproductive aging and declining ovarian reserve. [1]

Metformin, rapamycin, resveratrol and spermidine in the description

The description names metformin, rapamycin, resveratrol and spermidine as well-known compounds investigated in this field. Metformin is described as primarily known for metabolic effects and widely used for specific clinical indications; it is being studied as a possible caloric restriction mimetic, but the description says this is not a recommendation to use it solely for fertility or ovarian aging. Rapamycin is described as inhibiting mTOR and being studied experimentally for primordial follicle activation and ovarian aging; it remains experimental in reproductive medicine and should not be self-administered for fertility. Resveratrol is linked to SIRT1 and cellular stress pathways, and spermidine to autophagy and mitochondrial quality control. [1]

Animal and laboratory findings versus human fertility

The description says experimental research has investigated caloric restriction and CR-like interventions in relation to follicle preservation, oocyte quality and ovarian aging, particularly in animal models. It states that these findings should not be interpreted as proof that caloric restriction mimetics can currently reverse ovarian aging or improve pregnancy rates in women, and that human evidence remains limited with further clinical research required. It also says evidence from laboratory and animal studies cannot automatically be translated into proven fertility benefits in humans. On caloric restriction and low AMH, it says animal research suggests moderate restriction may affect follicle dynamics, while excessive restriction or inadequate energy availability can negatively affect reproductive function. [1]

Context & limits

This is based only on the supplied video description; the video and transcript were not reviewed. The description reports no study design, sample size, follow-up or human outcome data, and its statements about animal and laboratory work are attributed to the creator.

Based on the creator’s description; the full video and transcript were not analyzed.

[1] Caloric restriction (CR) for healthy living ? #youtubeshorts #shortsfeed
Quoted passages in the original language
without simply reducing food intake
should not be self-administered for fertility purposes
Human evidence remains limited

About this video

Creator description · original textText language: English (India)

Can caloric restriction mimetics really influence fertility, ovarian aging and ovarian reserve? In this video, Dr Rajat explains the fascinating science behind caloric restriction mimetics in fertility and why these metabolic pathways are attracting increasing attention in reproductive medicine. Caloric restriction mimetics are compounds or interventions that attempt to reproduce some of the cellular effects associated with caloric restriction without simply reducing food intake. Research has connected these pathways with nutrient sensing, cellular metabolism, autophagy, mitochondrial function, oxidative stress, AMPK, mTOR and sirtuin signaling. These mechanisms are particularly interesting when we discuss ovarian aging, reproductive aging and the decline in ovarian reserve. In this video, Dr Rajat explains the relationship between caloric restriction mimetics and fertility, caloric restriction and fertility, and the possible connection between metabolic health and ovarian function. We will discuss how caloric restriction mimetics may influence ovarian aging, ovarian reserve and cellular aging, and why researchers are studying these pathways as potential strategies for reproductive longevity. Experimental research has investigated caloric restriction and CR-like interventions in relation to follicle preservation, oocyte quality and ovarian aging, particularly in animal models. However, these findings should not be interpreted as proof that caloric restriction mimetics can currently reverse ovarian aging or improve pregnancy rates in women. Human evidence remains limited and further clinical research is required. One important question is: how do caloric restriction mimetics work? Several pathways are being investigated. AMPK is an important cellular energy sensor, while mTOR is involved in nutrient sensing, growth and cellular metabolism. Sirtuins, including SIRT1, are also closely associated with cellular aging and metabolic regulation. Autophagy and mitochondrial function are additional mechanisms of interest because healthy cellular recycling and mitochondrial activity are important for oocyte and ovarian function. The video also discusses some of the best-known compounds investigated in the caloric restriction mimetic field, including metformin, rapamycin, resveratrol and spermidine. METFORMIN AND FERTILITY Metformin is primarily known for its metabolic effects and is widely used in clinical medicine for specific indications. It has also been investigated as a potential caloric restriction mimetic because of its effects on AMPK and cellular metabolism. Researchers are studying whether metabolic modulation could influence ovarian aging and reproductive function, but this should not be interpreted as a recommendation to use metformin solely for fertility or ovarian aging. RAPAMYCIN AND OVARIAN AGING Rapamycin is one of the most frequently discussed pharmacological caloric restriction mimetics because it inhibits the mTOR pathway. Experimental studies have investigated whether mTOR modulation can influence primordial follicle activation and ovarian aging. However, rapamycin remains an experimental area in reproductive medicine and has important safety and reproductive considerations. It should not be self-administered for fertility purposes. RESVERATROL AND OVARIAN RESERVE Resveratrol has been studied because of its relationship with SIRT1 and cellular stress pathways. Experimental reproductive research has investigated whether resveratrol can influence ovarian aging, oxidative stress, mitochondrial function and oocyte quality. These findings are scientifically interesting, but evidence from laboratory and animal studies cannot automatically be translated into proven fertility benefits in humans. SPERMIDINE AND AUTOPHAGY Spermidine is another compound receiving attention in longevity and reproductive-aging research. It can influence autophagy and mitochondrial quality-control pathways. Experimental research has investigated spermidine in relation to oocyte aging and fertility, making it an interesting topic within the broader field of caloric restriction mimetics. CALORIC RESTRICTION, LOW AMH AND OVARIAN RESERVE Another important topic is the relationship between caloric restriction, low AMH and ovarian reserve. Research in animal models suggests that moderate caloric restriction may affect follicle dynamics and pathways associated with ovarian aging. However, excessive calorie restriction or inadequate energy availability can negatively affect reproductive function. Therefore, “less food” should not automatically be equated with “better fertility.” The field of ovarian aging is rapidly developing. Current research suggests that metabolic regulation may be connected to ovarian aging through pathways involving AMPK, mTOR, sirtuins, autophagy, mitochondria and oxidative stress. #Fertility #OvarianAging #LowAMH #OvarianReserve #CaloricRestriction #CRMimetics #Infertility #IVF #FertilityTreatment #DrRajat

The Fertility Gynecologist · 2 min · Source published: 2026-10-13

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…